An embryoprotective role for glucose-6-phosphate dehydrogenase in developmental oxidative stress and chemical teratogenesis

FASEB Journal

Volumn 14, Issue 1, 2000, Pages 111-127

  Nicol, Christopher J ^a   Zielenski, Julian ^b   Tsui, Lap Chee ^a,b   Wells, Peter G ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Birth defects; Development; Human risk; Phenytoin; Reactive oxygen species

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ARTICLE; BIRTH DEFECT; CHEMICAL TERATOGENESIS; EMBRYO DEVELOPMENT; FETUS DEATH; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH HAZARD; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALIA;

EID: 0033977661     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.14.1.111     Document Type: Article

References (70)

1. Mehta, A. B. (1994) Glucose-6-phosphate dehydrogenase deficiency. Postgrad. Med. J. 70, 871-877
2. Sodeinde, O. (1992) Glucose-6-phosphate dehydrogenase deficiency. Baill. Clin. Hematol. 5, 367-382
3. Halliwell, B., and Gutteridge, J. M. C. (1989) Free Radicals in Biology and Medicine. Clarendon, Oxford, U. K.
4. Wells, P. G., and Winn, L. M. (1996) Biochemical toxicology of chemical teratogenesis. Crit. Rev. Biochem. Mol. Biol. 31, 1-40
5. Wells, P. G., Kim, P. M., Nicol, C. J., Parman, T., and Winn, L. M. (1996) Reactive intermediates. In Handbook of Experimental Pharmacology: Drug Toxicity in Embryonic Development (Kavlock, R. J., and Daston, G. P., eds) Vol. 124, Part 1, pp. 453-518, Springer-Verlag, Heidelberg, Germany
6. Kirkman, H. N., and Gaetani, G. F. (1984) Catalase: a tetrameric enzyme with four tightly bound molecules of NADPH. Proc. Natl. Acad. Sci. USA 81, 4343-4347
7. Kirkman, H. N., Galiano, S., and Gaetani, G. F. (1987) The function of catalase-hound NADPH. J. Biol. Chem. 262, 660-666
8. Kirkman, H. N., Rolfo, M., Ferraris, A. M., and Gaetani, G. F. (1999) Mechanisms of protection of catalase by NADPH. J. Biol. Chem. 274, 13908-13914
9. Beutler, K. (1986) Drug-induced hemolytic anemia and non-spherocytic hemolytic anemia. In Glucose-6-Phosphate Dehydrogenase (Yoshida, A., and Beutler, E., eds) pp. 3-12, Academic, Orlando
10. Luzzatto, L., and Mehta, A. (1995) Glucose 6-phosphate dehydrogenase deficiency. In The Metabolic and Molecular Basis of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds) Vol. 7, pp. 3367-3398, McGraw-Hill, Toronto
11. Zollo, M., D'Urso, M., Schlessinger, D., and Chen, E. Y. (1993) Sequence of mouse glucose-6-phosphate dehydrogenase cDNA. DNA Seq.-J. DNA Seq. Map. 3, 319-322
12. Beutler, E. (1959) The hemolytic effect of primaquine and related compounds: a review. Blood 14, 103-109
13. Beutler, E. (1993) Study of glucose-6-phosphate dehydrogenase: history and molecular biology. Am. J. Hematol. 42, 53-58
14. Martini, G., and Ursini, M. V. (1996) A new lease of life for an old enzyme. BioEssays 18, 631-637
15. Beutler, E., Vulliamy, T., and Luzzatto, L. (1996) Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol. Dis. 22, 49-56
16. Abu-Osba, Y. K., Mallouh, A. A., and Hann, R. W. (1989) Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants. J. Pediatr. 114, 748-752
17. Winn, L. M., and Wells, P. G. (1995) Free radical-mediated mechanisms of anticonvulsant teratogenicity. Eur. J. Neurol. 2 (Suppl. 4), 5-29
18. Newburgh, R. W., Buckingham, B., and Herrmann, H. (1962) Levels of reduced TPN generating systems in chick embryos in ovo and in explants. Arch. Biochem. Biophys. 97, 94-99
19. Papaconstantinou, J. (1967) Metabolic control of growth and differentiation in vertebrate embryos. In The Biochemistry of Animal Development (Weber, R., ed) Vol. 2, pp. 57-113, Academic, New York
20. Winn, L. M., and Wells, P. G. (1995) Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity. Mol. Pharmacol. 48, 112-120
21. Sanders, S., Smith, D. P., Thomas, G. A., and Williams, E. D. (1997) A glucose-6-phosphate dehydrogenase (G6PD) splice site consensus sequence mutation associated with G6PD enzyme deficiency. Mutat. Res. 374, 79-87
22. Gupta, R. C. (1984) Nonrandom binding of the carcinogen N-hydroxy-2-acetylfluorene to repetitive sequences of rat liver DNA in vivo. Proc. Natl. Acad. Sci. USA 81, 6943-6947
23. Shigenaga, M. K., and Ames, B. N. (1991) Assay for 8-hydroxy-2′-deoxyguanosine: a biomarker of in vivo oxidative damage. Free Rad. Biol. Med. 10, 211-216
24. Chen, E. Y., Cheng, A., Lee, A., Kuang, W. J., Hillier, L., Green, P., Schlessinger, D., Ciccodicola, A., and D'Urso, M. (1991) Sequence of human glucose-6-phosphate dehydrogenase cloned in plasmids and a yeast artificial chromosome. Genomics 10, 792-800
25. Nicol, C. J., Harrison, M. L., Laposa, R. R., Gimelshtein, I. L., and Wells, P. G. (1995) A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat. Genet. 10, 181-187
26. Washington, E. C., Ector, W., Abboud, M., Ohning, B., and Holden, K. (1995) Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn. South. Med. J. 88, 776-779
27. Burt, A. M., and Wenger, B. S. (1961) Glucose-6-phosphate dehydrogenase activity in the brain of the developing chick. Dev. Biol. 3, 84-95
28. Jolley, R. L., Cheldelin, V. H., and Newburgh, R. W. (1958) Glucose catabolism in fetal and adult heart. J. Biol. Chem. 233, 1289-1294
29. Jolley, R. L., Cheldelin, V. H., and Newburgh, R. W. (1959) The catabolism of glucose in soluble adult and fetal-heart preparations. Biochim. Biophys. Acta 33, 64-68
30. Lucas, A. M., and Jamroz, C. (eds) (1961) Atlas of Avian Hematology, pp. 17-30, United States Department of Agriculture, Washington, D.C.
31. Sinclair, G. D., and Brasch, K. (1975) The nucleated erythrocyte: a model of cell differentiation. Revue Can. Biol. 34, 287-303
32. Ganshirt, D., Smeets, F. W., Dohr, A., Walde, C., Steen, I., Lapucci, C., Falcinelli, C., Sant, R., Velasco, M., Garritsen, H. S., and Holzgreve, W. (1998) Enrichment of fetal nucleated red blood cells from the maternal circulation for prenatal diagnosis: experience with triple density gradient and MACS based on more than 600 cases. Fetal Diagnostic Ther. 13, 276-86
33. Guyton, A. C. (ed) (1987) Red blood cells, white blood cells and resistance of the body to infection. In Human Physiology and Mechanisms of Disease, 4th Ed, p. 195, W. B. Saunders, Toronto
34. Singh, M., and Shah, G. L. (1989) Teratogenic effects of phenytoin on chick embryos. Teratology 40, 453-458
35. Pretsch, W., Charles, D. J., and Merkle, S. (1988) X-linked glucose-6-phosphate dehydrogenase (G6PD) deficiency in Mus musculus. Biochem. Genet. 26, 89-103
36. Finnell, R. H., and Chernoff, G. F. (1984) Variable patterns of malformation in the mouse fetal hydantoin syndrome. Am. J. Med. Genet, 19, 463-471
37. Wells, P. G., Kim, P. M., Laposa, R. R., Nicol, C. J., Parman, T., and Winn, L. M. (1997) Oxidative damage in chemical teratogenesis. Mutat. Res. 396, 65-78
38. Kim, P. M., and Wells, P. G. (1996) Phenytoin-initiated hydroxyl radical formation: characterisation by enhanced salicylate hydroxylation. Mol. Pharmacol. 49, 172-181
39. Parman, T., Chen, G., and Wells, P. G. (1998) Free radical intermediates of phenytoin and related teratogens: prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry and photochemical product analysis. J. Biol. Chem. 273, 25079-25088
40. Parman, T., Wiley, M. J., and Wells, P. G. (1999) Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nature Med. 5, 582-585
41. Winn, L. M., and Wells, P. G. (1999) Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity. Free Rad. Biol. Med. 26, 266-274
42. Laposa, R. R., and Wells, P. G. (1995) Preliminary evaluation of phenytoin teratogenicity in transgenic mice deficient in the p53 tumor suppressor gene. Fundam. Appl. Toxicol. 15, 161
43. Laposa, R. R., Chan, K. L., Wiley, M. J., and Wells, P. G. (1996) Enhanced phenytoin embryopathy in p53-deficient mice: characterisation of embryonic p53 genotype and the p53, p21 and Bax DNA damage response proteins. Fundam. Appl. Toxicol. 30(Suppl. 1, part 2), 195
44. Ursini, M. V., Parrella, A., Rosa, G., Salzano, S., and Martini, G. (1997) Biochem. J. 323 (Pt. 3), 801-806
45. Preville, X., Salvemini, F., Giraud, S., Chaufour, S., Paul, C., Stepien, G., Ursini, M. V., and Arrigo, A.-P. (1999) Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exp. Cell Res. 247, 61-78
46. Pandolfi, P. P., Sonati, F., Rivi, R., Mason, P., Grosveld, F., and Luzzatto, L. (1995) Targeted disruption of the housekeeping gene encoding glucose-6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J. 14, 5209-5215
47. Mayes, P.A. (1996) Biosynthesis of fatty acids. In Harper's Biochemistry (Murray, R. K., Granner, D. K., Mayes, P. A., and Rodwell, V. W., eds) 24th Ed, pp. 216-223, Appleton, and Lange, Stamford, CA
48. Robkin, M. A. (1997) Carbon monoxide and the embryo. Int. J. Dev. Biol. 41, 283-289
49. Tanimura, T., and Shepard, T. H. (1970) Glucose metabolism by rat embryos in vitro. Proc. Soc. Exp. Biol. Med. 135, 51-53
50. Aksu, O., Mackler, B., Shepard, T. H., and Lemire, R. J. (1968) Studies of the development of congenital anomalies in embryos of riboflavin-deficient, galactoflavin fed rats. Teratology 1, 93-102
51. 14C]glucose by postimplamation mouse embryos in vitro. J. Embryol. Exp. Morph. 74, 133-142
52. Edwards, R. G., and Fowler, R. E. (1959) Fetal mortality in adult mice after superovulation with gonadotrophins. J. Exp. Zool. 141, 299-322
53. West, J. D. (1993) A genetically defined animal model of anembryonic pregnancy. Hum. Reprod. 8, 1316-1323
54. Altman, P. L., and Dittmer, D. S. (1972) Biology Data Book, pp. 176-180, Federation of American Societies for Experimental Biology, Bethesda, MD
55. Werth, G., and Muller, G. (1967) Inheritable glucose-6-phosphate dehydrogenase deficiency in erythrocytes of rats. Klin. Wochenschr. 45, 265-269
56. Smith, J. E., Ryer, K., and Wallace, L. (1976) Glucose-6-phosphate dehydrogenase deficiency in a dog. Enzyme 21, 379-382
57. Graf, W. D., Oleinik, O. E., Pippenger, C. E., Eder, D. N., Glauser, T. A., and Shurtleff, D. B. (1995) Comparison of erythrocyte antioxidant enzyme activities and embryologic level of neural tube defects. Eur. J. Ped. Surgery 5 (Suppl. 1), 8-11
58. Weber, G. F., Maertens, P., Meng, X., and Pippenger, C. E. (1991) Glutathione peroxidase deficiency and childhood seizures. Lancet 337, 1443-1444
59. Willmore, L.J., and Rubin, J.J. (1981) Antiperoxidant pretrealnient and iron-induced epileptiform discharges in the rat: EEG and histopathologic studies. Neurology 31, 63-69
60. Balazs, L., and Leon, M. (1994) Evidence of an oxidative challenge in the Alzheimer's Brain. Neurochem. Res. 19, 1131-1137
61. Martins, R. N., Harper, C. G., Stokes, G. B., and Masters, C. L. (1986) Increased, cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J. Neurochem. 46, 1042-1045
62. Cooper, A. J., and Kristal, B. S. (1997) Multiple roles of glutathione in the central nervous system. J. Biol. Chem. 378, 793-802
63. Jenner, P. (1996) Oxidative stress in Parkinson's disease and other neurodegenerative disorders. Pathologie Biologie 44, 57-64
64. Ruwende, C., Khoo, S. C., Snow, R. W., Yates, S. N. R., Kwiatkowski, D., Gupta, S., Warn, P., Allsopp, C. E. M., Gilbert, S. C., Peschu, N., Newbold, C. I., Greenwood, B. M., Marsh, K., and Hill, A. V. S. (1995) Natural selection of hemi-and het for G6PD deficiency in Africa by resistance to severe malaria. Nature (London) 376, 246-249
65. Erel, O., Kocyigit, A., Avci, S., Aktepe, N., and Bulut, V. (1997) Oxidative stress and antioxidative status of plasma and erythrocytes in patients with vivax malaria. Clin. Biochem. 30, 631-639
66. Friedman, M. J. (1979) Oxidant damage mediates variant red cell resistance to malaria. Nature (London) 280, 245-247
67. Eckman, J. R., and Eaton, J. W. (1979) Dependence of plasmodial glutathione metabolism on the host cell. Nature (London) 278, 754-756
68. Yuthavong, Y., Bunyaratvej, A., and Kamchonwongpaisan, S. (1990) Increased susceptibility of malaria-infected variant erythrocytes to the mononuclear phagocyte system. Blood Cells 16, 591-597
69. Roth, E. F., Jr., Raventos-Suarez, C., Rinaldi, A., and Nagel, R. L. (1983) Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of plasmodium falciparum. Proc. Natl. Acad. Sci. USA 80, 298-299
70. Kosower, N. S., and Kosower, E. M. (1970) Molecular basis for selective advantage of glucose-6-phosphate dehydrogenase-deficient individuals exposed to malaria. Lancet 2, 1343-1344